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Inherited structural polymorphism in human complement proteins has been 
found in  C3  (1,  2),  properdin factor  B  (3), and  C6  (4). Evidence has  been 
presented that the gene for factor B (Bf) is closely linked to the major histocom- 
patibility locus in man (5) and in the rhesus monkey (6). From linkage analysis 
in families, it appears that the distance between Bf and HLA-B  on the sixth 
human chromosome is approximately 2-6 centimorgans (7-9),  and the distance 
between these two loci in the rhesus is similar (6). Evidence for genetic linkage 
has also recently been obtained between C6, B f, and HLA ~  with an approximate 
distance between C6 andHLA ofl5 centimorgans. Other workers have found no 
evidence for C6-HLA  linkage (10). Other observations indicate linkage of the 
locus for C4 deficiency in  the  guinea pig with the  major histocompatibility 
complex (MHC) in that species (11), and there may also be linkage between C4 
deficiency and the MHC in man (12). 
The gene for C2 deficiency in man is closely linked to the MHC (13-15),  and 
moreover there is marked linkage cl~equilibrium in that, in a large number of 
instances, the C2 deficiency gene is in linkage with HLA-A10 B18 (13-15), HLA- 
Dw2 (16), and BfS (9). The distance between the genes for C2 deficiency and for 
HLA-B  is similar to that between the genes for HLA-B and for Bf,  about 5 
centimorgans (9,  17). The present studies are concerned with genetic polymor- 
phism in C2 and possible linkage of this structural locus to Bf. 
Materials and Methods 
Serum Samples.  Serum samples were obtained by centrifugation of whole blood allowed to 
clot at room temperature for about 30 min and at 4°C for 1 h. The serum was stored at -80°C and 
thawed before analysis. However, samples kept at 4°C for up to 1 wk or thawed and frozen up to 
five times gave identical patterns of normal intensity. 
Isoelectric Focusing in Thin-Layer Polyacrylamide Gel.  The method described by Awdeh et al. 
(18),  modified  as  delineated  previously  (4),  was  used.  Ampholines  (LKB  Instruments,  Inc., 
Rockville,  Md.)  at  a  final  concentration  of 2%  (six  parts  pH  5-8,  one  part  pH  3.5-10)  were 
incorporated into 5% acrylamide gels with 0.2 M taurine. Gels were polymerized with riboflavin 
and light. Samples were applied by moistening small rectangles of Whatman no. 1 filter paper and 
placing them on the gel surface near the anode. 
Developing Gel.  Upon completion of isoolectric focusing, the acrylamide gel was layered with 
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l-ram thick 0.6% agarose in isotonic Veronal-buffered saline at pH 7.4 containing 0.1% gelatin, l 
×  10  -3 M Mg  ++ and 1.5  ×  10  -4 M Ca ++, 0.8% sheep erythrocytes sensitized with rabbit antibody 
(EA), and 6.7%  homozygous C2-deficient serum (19).  The undiluted C2-deficient serum and EA 
were preincubated for 70 s at 37°C and then mixed with the agarose solution in buffer at 45-50°C. 
After gelation, plates were placed in an incubator at 37°C. Patterns usually began to appear by 1 h 
and were optimal at 4 h. This method is the same as that published by Hobart and Lachmann (20). 
Results 
Serum from most individuals showed C2 patterns consisting of two prominent 
bands oflysis and two or three additional bands acidic or basic to these, as can be 
seen  in  Fig.  1.  Rare  sera  showed basic duplication  of the  major bands  (and 
perhaps  of the minor bands as well),  and  a  single  sample  from a  Caucasian 
showed acidic duplication of the major and some minor bands of lysis (Fig.  1). 
The variant bands tended to develop more slowly than the common bands and 
did  not  achieve  equal  intensity  by  4  h.  Serum  samples  from  five  subjects 
homozygous for C2 deficiency gave no patterns. 
The common C2 has been designated as C2 C (for common), the rare basic type 
as C2 B, and the rare acidic type as C2 A. The respective genes are C2 c, C2 B, and 
C2  A . 
Table I lists the incidence of C2 variants in the various populations examined. 
The overall incidence of variants was 3.75%, and it is evident that they occur in 
all major races. 
The families (LR, Th, and En) of three persons with C2 variants were studied. 
Family  LR was  reported  previously  in  relation  to  C3  deficiency  (21).  In  11 
subfamilies  with  one  parent  heterozygous for C2 A or C2 B,  24  of 51  children 
inherited the variant C2.  Moreover, about half the heterozygotes were males, 
and there was male to male transmission of the C2 variant,  indicating autoso- 
mal codominant inheritance.  Factor B types are shown in Fig. 2 where they are 
informative  for  analysis  of Bf-C2  linkage.  It  is  seen  that  no  instances  of 
crossovers between C2 and Bf were encountered. The led score for this linkage 
calculated from these relatively few informative matings was 3.6 at 0 -<0.005. 
This indicates the odds for linkage are nearly 4,000:1. Thus,  it appears highly 
likely that the C2 structural locus is closely linked to Bfand, therefore, probably 
to the MHC and the other complement genes linked to the MHC on the sixth 
human chromosome. 
Discussion 
Isoelectric focusing in liquid medium was applied by Colten and coworkers 
(22) to examine possible genetic polymorphism in human C2. All human sera 
examined gave a single band. The failure to detect the multiple bands of C2 in 
all sera and the small differences in pI that characterize the genetic variants, as 
seen  in  the  present  study,  must  be  ascribed  to  the  relative  insensitivity  of 
isoelectric focusing in liquid compared with isoelectric focusing in gel. 
The  existence  of genetic  polymorphism  in  human  C2  has  been  found  by 
Hobart and Lachmann  (10) who also obtained evidence for linkage between C2 
and HLA in a family with four informative children and no crossing over. Their 
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FIG. i.  Patterns  of C2 in normal human  sera as obtained  by isoelectric  focusing in 
polyacrylamide gel  and development of  bands of  lysis  in  an  overlay agarose gel  containing 
EA and C2-deficient  human serum. Common  C2 (C2  C)  is  shown in  a homozygote, and  the 
acidic  (C2  A)  and  basic  (C2  B)  variants  are  shown in  heterozygotes  who  also  possess  C2  C. 
TABLE  I 
C2 Variants Among Random Unrelated Individuals 
No. tested  C2 BC  C2 AC 
Orientals  43  3  0 
Cavt,~z~r~  75  3  1 
Negroes  3  0  2  0 
Utmpe~ied  92  0  0 
The fact that both the acidic and basic structural variants of C2 develop more 
slowly than C2 C and are of lesser intensity suggests the possibility that the 
structural mutations involved alter the hemolytic function of C2.  It  is  also 
possible these structural variants are associated with diminished concentration 
of the gene product in serum, as occurs with structural variants of al-antitryp- 
sin (23). 
The probable colocalization of the loci for C2 deficiency and C2  structural 
polymorphism on the sixth chromosome suggests that the deficiency state for 
C2,  like that for C3  (21, 24), involves a  blank allele of the structural genes. 
Alternatively, it  might result from inheritance of a  faulty regulatory gene 
closely situated on the chromosome to the structural gene. The proximity of the 
structural genes for C2 and factor B  is consistent with the possibility of the 
origin of C2 by tandem gene duplication from Bf. 
Summary 
Structural  variation in  the  second component of human complement was 
identified in about 4% of serum samples from random unrelated individuals of 1114  CHESTER  A.  ALPER  BRIEF  DEFINITIVE  REPORT 
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Fro.  2.  The inheritance of C2 variants in two kindred informative for linkage with Bf. 
Males are shown as squares, females as circles.  Generation numbers are denoted by Roman 
numerals to the left of  each family and individual identification numbers (within the larger 
kindred) are given at the upper right corner of each symbol. The presence of a basic variant 
(in the LR family) and an acidic variant (En family) is indicated by half-blackened symbols. 
Bf types are given below each symbol. 
all  the  major races.  Three forms of C2  have  been  identified by  isoelectric 
focusing in  polyacrylamide gel  and  development of patterns in  agarose  gel 
containing antibody-sensitized sheep red cells and C2-deficient serum: C2  C 
(common), C2 A (acidic),  and C2 B (basic).  The C2 variants were shown to be 
inherited as  autosomal codominant traits,  and suggestive evidence for close 
linkage between C2 and Bf was obtained. 
We are grateful for the expert technical assistance of Ms. Lillian Watson (deceased) and Ms. Vicki 
Mattson. 
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